Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

David Becton

Concepts (162)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
2
2009
27
0.640
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2011
1056
0.550
 Why?
Leukemia, Myeloid, Acute
4
2010
191
0.430
 Why?
Osteosarcoma
2
2016
37
0.360
 Why?
von Willebrand Diseases
1
2009
21
0.350
 Why?
Hematology
1
2009
26
0.350
 Why?
Sclerotherapy
2
2020
47
0.340
 Why?
Blood Coagulation Factor Inhibitors
1
2007
3
0.300
 Why?
Hemophilia B
1
2007
4
0.300
 Why?
Vascular Malformations
2
2020
101
0.300
 Why?
Hemostasis, Surgical
1
2007
12
0.300
 Why?
Blood Coagulation Factors
1
2007
19
0.300
 Why?
Enoxaparin
1
2007
25
0.300
 Why?
Antineoplastic Agents
4
2016
1300
0.300
 Why?
Blood Loss, Surgical
1
2007
79
0.290
 Why?
Child, Preschool
13
2020
4147
0.290
 Why?
Venous Thrombosis
1
2007
102
0.270
 Why?
Cyclosporine
1
2005
66
0.270
 Why?
Cisplatin
3
2016
352
0.260
 Why?
Blood Coagulation Disorders
2
2020
37
0.260
 Why?
Hemostasis
2
2020
56
0.260
 Why?
Leukemia
1
2005
69
0.260
 Why?
Cladribine
1
2004
4
0.250
 Why?
Bone Regeneration
2
2016
71
0.250
 Why?
Histiocytosis, Langerhans-Cell
1
2004
24
0.240
 Why?
Retinal Neoplasms
1
2003
13
0.230
 Why?
Retinoblastoma
1
2003
16
0.230
 Why?
Infant
11
2018
3817
0.220
 Why?
Neoplasms, Second Primary
1
2003
77
0.220
 Why?
Child
13
2020
7341
0.200
 Why?
Bone Neoplasms
1
2003
193
0.200
 Why?
Neoplasms
2
2012
1316
0.190
 Why?
Thrombelastography
1
2020
28
0.190
 Why?
Adolescent
11
2020
6897
0.180
 Why?
Bleomycin
1
2018
37
0.160
 Why?
Down Syndrome
3
2008
100
0.150
 Why?
Antibiotics, Antineoplastic
1
2018
85
0.150
 Why?
Osteogenesis, Distraction
2
2016
72
0.150
 Why?
Piperazines
2
2016
116
0.140
 Why?
Leukemia, Megakaryoblastic, Acute
2
2006
9
0.140
 Why?
Leukemia, Myeloid
2
2008
54
0.140
 Why?
Disease-Free Survival
5
2010
485
0.140
 Why?
Humans
20
2020
54284
0.130
 Why?
Remission Induction
4
2011
221
0.130
 Why?
Imidazoles
1
2016
142
0.130
 Why?
Male
13
2020
27334
0.130
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2009
105
0.120
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2013
40
0.120
 Why?
Doxorubicin
2
2005
259
0.110
 Why?
Survival Analysis
4
2010
735
0.110
 Why?
Cord Blood Stem Cell Transplantation
1
2011
5
0.100
 Why?
Sarcoma, Myeloid
1
2011
22
0.100
 Why?
Heart Neoplasms
1
2011
30
0.100
 Why?
Neutropenia
1
2012
120
0.100
 Why?
Core Binding Factors
1
2010
2
0.090
 Why?
Treatment Outcome
7
2018
5604
0.090
 Why?
Proto-Oncogene Proteins c-kit
1
2010
35
0.090
 Why?
Entamoebiasis
1
2009
2
0.090
 Why?
Liver Abscess
1
2009
4
0.090
 Why?
Diarrhea, Infantile
1
2009
5
0.090
 Why?
Listeriosis
1
2009
7
0.090
 Why?
Anemia, Aplastic
1
2009
12
0.090
 Why?
Platelet Transfusion
1
2009
32
0.090
 Why?
Female
10
2020
28441
0.090
 Why?
Acute Lung Injury
1
2009
19
0.090
 Why?
Histocompatibility Testing
1
2008
11
0.080
 Why?
HLA Antigens
1
2008
55
0.080
 Why?
Abdominal Pain
1
2009
77
0.080
 Why?
Young Adult
5
2020
4318
0.080
 Why?
Bone Marrow Transplantation
1
2008
149
0.080
 Why?
Hospitals, Pediatric
1
2009
272
0.080
 Why?
Adult
7
2020
14207
0.080
 Why?
Retrospective Studies
5
2018
6432
0.070
 Why?
Infusions, Intravenous
2
2004
231
0.070
 Why?
Cardiomyopathies
1
2008
129
0.070
 Why?
Mitolactol
1
2005
2
0.070
 Why?
GATA1 Transcription Factor
1
2005
7
0.070
 Why?
Leukocyte Count
1
2005
77
0.070
 Why?
Karyotyping
1
2005
92
0.070
 Why?
Tamoxifen
1
2005
60
0.070
 Why?
Gene Expression Regulation, Neoplastic
2
2006
866
0.060
 Why?
Heart
1
2008
360
0.060
 Why?
Receptor Protein-Tyrosine Kinases
1
2004
52
0.060
 Why?
Immunosuppressive Agents
1
2005
248
0.060
 Why?
Humerus
1
2003
21
0.060
 Why?
Proto-Oncogene Proteins
1
2004
169
0.060
 Why?
Arkansas
1
2009
2100
0.060
 Why?
Tibia
1
2003
117
0.060
 Why?
Methotrexate
1
2003
73
0.060
 Why?
Topotecan
1
2002
19
0.050
 Why?
Survivors
1
2003
137
0.050
 Why?
Mutation
2
2010
1501
0.050
 Why?
Blood Coagulation Tests
1
2020
23
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2013
434
0.050
 Why?
Blood Flow Velocity
1
2020
114
0.050
 Why?
Blood Coagulation
1
2020
69
0.050
 Why?
Dose-Response Relationship, Drug
1
2004
1476
0.050
 Why?
Prognosis
3
2012
2118
0.040
 Why?
Follow-Up Studies
2
2018
2387
0.040
 Why?
Mice, Inbred C57BL
2
2016
1999
0.040
 Why?
Hemorrhage
1
2020
208
0.040
 Why?
Gene Expression Profiling
1
2004
1138
0.040
 Why?
Daunorubicin
2
2008
12
0.040
 Why?
Cytarabine
2
2006
39
0.040
 Why?
Xenograft Model Antitumor Assays
1
2016
219
0.030
 Why?
Mice, Nude
1
2016
283
0.030
 Why?
Random Allocation
1
2016
312
0.030
 Why?
Acute Disease
2
2008
403
0.030
 Why?
Cluster Analysis
2
2005
249
0.030
 Why?
Prospective Studies
2
2012
2604
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
474
0.030
 Why?
Interleukin-3
1
2012
13
0.030
 Why?
Calcitonin Gene-Related Peptide
1
2012
24
0.030
 Why?
Calcitonin
1
2012
38
0.030
 Why?
Protein Precursors
1
2012
47
0.030
 Why?
Interleukin-8
1
2012
97
0.030
 Why?
Interleukin-10
1
2012
107
0.030
 Why?
ROC Curve
1
2012
259
0.030
 Why?
Fatal Outcome
1
2011
225
0.020
 Why?
Mice, Knockout
1
2013
926
0.020
 Why?
Intensive Care Units
1
2012
231
0.020
 Why?
Interleukin-6
1
2012
315
0.020
 Why?
Exons
1
2010
105
0.020
 Why?
Pilot Projects
1
2012
808
0.020
 Why?
Opportunistic Infections
1
2009
58
0.020
 Why?
Animals
2
2016
14385
0.020
 Why?
Echocardiography
1
2011
392
0.020
 Why?
Mitoxantrone
1
2008
11
0.020
 Why?
Translocation, Genetic
1
2010
287
0.020
 Why?
Hospitalization
1
2012
705
0.020
 Why?
Proportional Hazards Models
1
2008
431
0.020
 Why?
Recurrence
1
2008
690
0.020
 Why?
Prevalence
1
2010
1025
0.020
 Why?
Immunophenotyping
1
2006
117
0.020
 Why?
Genetic Predisposition to Disease
1
2010
570
0.020
 Why?
Nucleic Acid Hybridization
1
2005
54
0.020
 Why?
Luciferases
1
2005
57
0.020
 Why?
Tomography, X-Ray Computed
1
2011
1213
0.020
 Why?
DNA Primers
1
2005
225
0.020
 Why?
Cell Membrane
1
2006
278
0.020
 Why?
Diagnosis, Differential
1
2009
1136
0.020
 Why?
Middle Aged
1
2020
13088
0.020
 Why?
Tumor Cells, Cultured
1
2005
477
0.020
 Why?
Core Binding Factor Alpha 3 Subunit
1
2004
1
0.020
 Why?
Transfection
1
2005
399
0.020
 Why?
fms-Like Tyrosine Kinase 3
1
2004
16
0.020
 Why?
Benzamides
1
2004
54
0.020
 Why?
Magnetic Resonance Imaging
1
2011
1604
0.020
 Why?
Sensitivity and Specificity
1
2006
923
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
673
0.010
 Why?
Risk Assessment
1
2008
1361
0.010
 Why?
Risk Factors
1
2012
3935
0.010
 Why?
Pyrimidines
1
2004
196
0.010
 Why?
DNA Helicases
1
2004
132
0.010
 Why?
Nuclear Proteins
1
2004
252
0.010
 Why?
Mice
1
2013
6413
0.010
 Why?
Time Factors
1
2008
3213
0.010
 Why?
DNA-Binding Proteins
1
2004
462
0.010
 Why?
Drug Administration Schedule
1
2002
401
0.010
 Why?
Predictive Value of Tests
1
2004
1048
0.010
 Why?
Transcription Factors
1
2004
622
0.010
 Why?
Infant, Newborn
1
2006
2907
0.010
 Why?
Becton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (162) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department